Monday 20 September 2021

Reuters Global Healthcare: U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC

U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC

The United States has administered 386,237,881 doses of COVID-19 vaccines in the country as of Monday morning, the U.S. Centers for Disease Control and Prevention said.

Vaccine skeptic Bolsonaro gets a pass at U.N. but not New York restaurants

Unvaccinated heads of state attending the United Nation General Assembly this week may have to settle for a piece of pizza on a sidewalk instead of fine dining at New York's restaurants.

India set to get first J&J COVID vaccine doses in October, says source

India expects to get its first Johnson & Johnson COVID-19 vaccine doses from next month, filled and finished in India by a partner of the U.S. drugmaker, a source with knowledge of the matter told Reuters on Monday.

COVID creates shortages of an array of U.S. medical supplies

Shortages of masks and gloves that marked the early days of the COVID-19 pandemic have spread to a host of other items needed at medical facilities in the United States, from exam tables and heart defibrillators to crutches and IV poles.

Illumina expects EU order to keep Grail a separate company

Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

Vatican says to require COVID-19 health pass for residents, visitors

A health certificate showing proof of immunity from COVID-19 will be required to enter the Vatican as of Oct. 1, the city state said on Monday.

Austria will require masks, COVID-19 passes for ski lifts

Austria will require protective face masks and COVID-19 passes for the use of ski lifts this winter as it tries to attract foreign skiers for the first time in two years and also prevent coronavirus outbreaks.

U.S. FDA approves first biosimilar rival to Roche's blockbuster eye drug

The U.S. Food and Drug Administration on Monday approved South Korean drugmaker Samsung Bioepis Co Ltd and Biogen Inc's biosimilar rival to Roche Holding AG's blockbuster eye drug, Lucentis.

NextGen Healthcare hires Sides from Teladoc Health as CEO

NextGen Healthcare Inc said on Monday it has hired healthcare information technology veteran David Sides as its chief executive officer, three months after his predecessor left.

Mirati Therapeutics taps industry veteran Meek as CEO

Mirati Therapeutics Inc named industry veteran David Meek as its chief executive officer on Monday as it pushes on with the development of its promising candidates for cancer treatment.

Related Videos

Only Pfizer to start U.S. booster plan -source

Number of dementia cases set to jump 40% by 2030

Can llamas' antibodies help fight COVID?